FindTrial
Sign In

Comparative study between Albumin and Normal saline for the management of ICU admitted critically ill patients

Albumin versus crystalloids in fluid resuscitation in severe sepsis and septic shock

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/037734
Enrollment
90
Registered
2021-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A049- Bacterial intestinal infection, unspecified Health Condition 2: O- Medical and Surgical Health Condition 3: A419- Sepsis, unspecified organism

Interventions

Intervention1: RESUSCITATING PATIENTS OF SEPSIS AND SEPTIC SHOCK WITH ALBUMIN 20%: PATIENTS WITH SEPSIS AND SEPTIC SHOCK WILL RANDOMLY BE DIVIDED INTO 2 GROUPS.GROUP A WILL RECEIVE ALBUMIN 20% AT 0.5

Sponsors

VIMSAR
Lead Sponsor
Dr Sumati Kandi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)AGE-18-70 YEARS 2)AFTER OBTAINING INFORMED CONSENT WE WILL INCLUDE ADULT PATIENTS WITH SEVERE SEPSIS AND SEPTIC SHOCK WITH I)WBC LEVEL >12000 OR II)HEART RATE >90/MINUTES III)SYSTOLIC BLOOD PRESSURE IV)URINE OUTPUT V)LACTATE LEVEL >2 MILIEQUIVALENTS/L 2.ASA GRADE I AND II

Exclusion criteria

Exclusion criteria: 1.PREGNANT WOMEN AND LACTATING MOTHERS 2.CHILDREN 3.ACUTE BURN PATIENTS 4.HEART FAILURE

Design outcomes

Primary

MeasureTime frame
TO COMPARE THE EFFECTS OF ALBUMIN AND CRYSTALLOIDS ON INCIDENCE OF MORTALITY IN PATIENTS WITH SEVERE SEPSIS AND SEPTIC SHOCK.Timepoint: NOVEMBER 2019 TO OCTOBER 2021—

Secondary

MeasureTime frame
TO ASSESS THE TIME TO SHIFT PATIENTS TO GENERAL WARDS.Timepoint: NOVEMBER 2019 TO OCTOBER 2021—

Countries

India

Contacts

Public ContactPREMANJALI JENA

Department of Anesthesiology, VSS Medical College

premanjali.jena@rediffmail.com7735430513

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026